trihexyphenidyl has been researched along with Basal Ganglia Diseases in 35 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An electromyographic method was used to study the effect of combination therapy with L-dopa and trihexyphenidyl on tremor in thirty patients suffering from extrapyramidal motor system disease." | 7.66 | Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor. ( Hökendorf, H, 1979) |
| "An electromyographic method was used to study the effect of combination therapy with L-dopa and trihexyphenidyl on tremor in thirty patients suffering from extrapyramidal motor system disease." | 3.66 | Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor. ( Hökendorf, H, 1979) |
| "Acute withdrawal is therefore unjustified, but occasional revision of dosage of anti-Parkinsonian drugs is advisable." | 2.64 | Benzhexol and side effects with long-acting fluphenazine therapy. ( Crammer, JL; Grove, L, 1972) |
| " Though both blepharospasm and OMD are thought to represent focal dystonia at different body sites, the extent of improvement achieved with these drugs at the dosage employed differed markedly." | 1.27 | Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics. ( Giménez-Roldán, S; Hípola, D; Mateo, D, 1984) |
| "In older patients hemidystonia appeared within 6 months after injury." | 1.27 | Hemidystonia: a report of 22 patients and a review of the literature. ( Jankovic, J; Pettigrew, LC, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (88.57) | 18.7374 |
| 1990's | 1 (2.86) | 18.2507 |
| 2000's | 2 (5.71) | 29.6817 |
| 2010's | 1 (2.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aravind, VK | 1 |
| Krishnaram, VD | 1 |
| Neethiarau, V | 1 |
| Srinivasan, KG | 1 |
| Verma, R | 1 |
| Lalla, R | 1 |
| Patil, TB | 1 |
| MULLER, L | 1 |
| ANDERSSON, B | 1 |
| KUVER, G | 1 |
| GOEBEL, U | 1 |
| Grosse, P | 1 |
| Edwards, M | 1 |
| Tijssen, MAJ | 1 |
| Schrag, A | 1 |
| Lees, AJ | 1 |
| Bhatia, KP | 1 |
| Brown, P | 1 |
| Manos, N | 1 |
| Gkiouzepas, J | 1 |
| Ungvári, G | 1 |
| Bitter, I | 1 |
| Czobor, P | 1 |
| Vitrai, J | 1 |
| Pethö, B | 1 |
| Stoudemire, A | 1 |
| Luther, JS | 1 |
| Irwin, GE | 1 |
| Simon, JE | 1 |
| Hípola, D | 2 |
| Mateo, D | 2 |
| Giménez-Roldán, S | 2 |
| Duvoisin, RC | 1 |
| Daniel, AE | 1 |
| Chapel, JL | 1 |
| Schwartz, M | 1 |
| Weller, B | 1 |
| Erdreich, M | 1 |
| Sharf, B | 1 |
| Allain, H | 1 |
| Bentue-Ferrer, D | 1 |
| Brissot, R | 1 |
| Morisot, D | 1 |
| Madigand, M | 1 |
| Menault, F | 1 |
| Hökendorf, H | 1 |
| Rubinstein, JS | 1 |
| Jellinek, T | 1 |
| Alpert, M | 1 |
| Diamond, F | 1 |
| Laski, EM | 1 |
| Yosselson, S | 1 |
| Kaplan, A | 1 |
| Stimmel, GL | 1 |
| McEvoy, JP | 1 |
| Hitri, A | 1 |
| Craft, RB | 1 |
| Sethi, R | 1 |
| Sinha, D | 1 |
| Orbe, M | 1 |
| Muñoz-Blanco, JL | 1 |
| Faulstich, ME | 1 |
| Carnrike, CL | 1 |
| Williamson, DA | 1 |
| McInnis, M | 1 |
| Petursson, H | 1 |
| Pettigrew, LC | 1 |
| Jankovic, J | 1 |
| Shintomi, K | 1 |
| Yamamura, M | 1 |
| Chase, TN | 1 |
| Black, D | 1 |
| Woollacott, S | 1 |
| Grove, L | 1 |
| Crammer, JL | 1 |
| Klett, CJ | 1 |
| Caffey, E | 1 |
| Dreyfuss, J | 1 |
| Beer, B | 1 |
| Devine, DD | 1 |
| Roberts, BF | 1 |
| Schreiber, EC | 1 |
| Bastecký, J | 1 |
| Vinar, O | 1 |
| Taussigová, D | 1 |
| Villeneuve, A | 1 |
2 reviews available for trihexyphenidyl and Basal Ganglia Diseases
| Article | Year |
|---|---|
Blepharospasm and Meige syndrome: a review of diagnostic, aetiological and treatment approaches.
Topics: Acetylcholine; Basal Ganglia; Basal Ganglia Diseases; Behavior Therapy; Biofeedback, Psychology; Ble | 1985 |
Drug-induced extrapyramidal disorders.
Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopa | 1972 |
5 trials available for trihexyphenidyl and Basal Ganglia Diseases
| Article | Year |
|---|---|
Discontinuing antiparkinson medication in chronic schizophrenics. At what cost to the patient?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blin | 1981 |
A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
Topics: Adult; Age Factors; Aged; Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Benztropine; Cli | 1987 |
Withdrawal of trihexyphenidyl.
Topics: Adult; Anxiety; Basal Ganglia Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Psyc | 1985 |
Benzhexol and side effects with long-acting fluphenazine therapy.
Topics: Administration, Oral; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Female; Fluphen | 1972 |
Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
Topics: 1-Propanol; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Benztropine; Biperiden; Chronic Dis | 1972 |
28 other studies available for trihexyphenidyl and Basal Ganglia Diseases
| Article | Year |
|---|---|
Wilson's disease--a rare psychiatric presentation.
Topics: Adrenergic Uptake Inhibitors; Adult; Basal Ganglia Diseases; Diagnosis, Differential; Hepatolenticul | 2009 |
Is blinking of the eyes affected in extrapyramidal disorders? An interesting observation in a patient with Wilson disease.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blinking; Carbidopa; Ceruloplasmin; Drug Therap | 2012 |
[Mental disorders as complication of pargitan therapy of extrapyramidal symptoms].
Topics: Basal Ganglia Diseases; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorders; | 1953 |
[Comparative research on new drugs for the treatment of extrapyramidal motor disorders].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Humans; Muscle Relaxan | 1955 |
[Clinical results with artane in parkinsonism and other extrapyramidal syndromes].
Topics: Basal Ganglia Diseases; Extrapyramidal Tracts; Parkinsonian Disorders; Syndrome; Trihexyphenidyl | 1951 |
Patterns of EMG-EMG coherence in limb dystonia.
Topics: Adult; Anterior Compartment Syndrome; Anti-Dyskinesia Agents; Anticonvulsants; Antiparkinson Agents; | 2004 |
[The role of high-dosage neuroleptic therapy and electroshock in the treatment of the acute phase of schizophrenia].
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Electroconvul | 1981 |
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; F | 1984 |
Neuroleptic malignant syndrome.
Topics: Basal Ganglia Diseases; Chronic Disease; Diagnosis, Differential; Dibenzoxazepines; Dose-Response Re | 1984 |
Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics.
Topics: Aged; Basal Ganglia Diseases; Benzodiazepinones; Clonazepam; Dystonia; Female; Follow-Up Studies; Hu | 1984 |
Meige syndrome: relief on high-dose anticholinergic therapy.
Topics: Ambenonium Chloride; Basal Ganglia Diseases; Benztropine; Carbidopa; Humans; Parasympatholytics; Tri | 1983 |
Tics of Tourette: important points in management.
Topics: Basal Ganglia Diseases; Child; Child, Preschool; Female; Haloperidol; Humans; Male; Tourette Syndrom | 1981 |
Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Diagnosis, Differential; Dyskinesia, Drug-Induced; Fem | 1995 |
[Shy and Drager syndrome. Physiopathological and pharmacological approach based upon one case (author's transl)].
Topics: Basal Ganglia Diseases; Dibenzazepines; Drug Therapy, Combination; Humans; Hypotension, Orthostatic; | 1979 |
Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor.
Topics: Aged; Basal Ganglia Diseases; Drug Therapy, Combination; Electromyography; Female; Humans; Levodopa; | 1979 |
Abuse of antiparkinsonism drugs. Feigning of extrapyramidal symptoms to obtain trihexyphenidyl.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Diagnosis, Differential; Female; Humans; Maling | 1978 |
Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication.
Topics: Adolescent; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Biperiden; Emotions; Euphoria; Fema | 1977 |
Anticholinergic exacerbation of phenothiazine-induced extrapyramidal syndrome.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Humans; Substance Withdrawal Syndrome; Trifluoperazin | 1976 |
Letter: Neurotoxic reaction to haloperidol in a thyrotoxic patient.
Topics: Adult; Basal Ganglia Diseases; Diphenhydramine; Female; Haloperidol; Humans; Hyperthyroidism; Trihex | 1975 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloper | 1976 |
Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benztropine; | 1987 |
Acute pharmacologic tests in cranial dystonia.
Topics: Adult; Aged; Basal Ganglia Diseases; Clonazepam; Diagnosis, Differential; Double-Blind Method; Femal | 1988 |
Hemidystonia: a report of 22 patients and a review of the literature.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain Damage, Chronic; Brain Diseases; Brain Injuri | 1985 |
Letter: Effects of antiparkinsonian drugs on neuroleptic-induced extrapyramidal signs in monkeys.
Topics: Animals; Antiparkinson Agents; Basal Ganglia Diseases; Benztropine; Glycolates; Haloperidol; Haplorh | 1973 |
Acute toxic psychosis in two children treated with benzhexol hydrochloride (Artane).
Topics: Adolescent; Basal Ganglia Diseases; Child, Preschool; Female; Humans; Hyperkinesis; Psychoses, Subst | 1974 |
Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Carbon Isotopes; Chromatography, Thin Layer; Feces; Fe | 1972 |
Extrapyramidal symptoms in the course of fluphenazine treatment.
Topics: Adult; Basal Ganglia Diseases; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Move | 1972 |
The rabbit syndrome. A peculiar extrapyramidal reaction.
Topics: Aged; Anxiety; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Fatigue; Female; Humans; Male; M | 1972 |